The Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) ：Single-arm, Prospective, Open Clinical Study
Clinical trial NCT06125080 · RECRUITING
Trial details
- NCT number
- NCT06125080
- Sponsor
- Huihua Xiong
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-30
- Primary completion
- 2025-10-30
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.